Biography

Professor Juan-Carlos Kaski is an honorary consultant cardiologist at our diagnostics and outpatient facility at 77 Wimpole Street, where he treats private patients. 

He is Editor-in-Chief of European Cardiology Review Journal, Deputy Editor (IHD) of European Heart Journal and a member of the editorial board of over twenty major scientific journals, including the European Journal of Cardiology and the Journal of the American College of Cardiology, as well as immediate past associate editor of Cardiovascular Drugs and Therapy.

Prof Kaski is Doctor Honoris Causa of the University of St Luis in Argentina and the University Carol Davila, Bucharest. He has received numerous scientific and educational awards, including the Gold Medal of the Spanish Society of Cardiology, Scientiae Magistri Award (Rome), RAICES award (Argentina) and Fukushima University award (Japan), for his contribution to cardiovascular research and teaching.

Professor Kaski is Chairman-Elect of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and the immediate past President and Chair of the Executive Board of the International Society of Pharmacotherapy, an affiliate member of the World Heart Federation.

Clinical expertise

Professor Juan-Carlos Kaski has specialist clinical expertise in:

  • Angina pectoris
  • Coronary artery disease
  • Microvascular angina
  • Coronary artery spasm
  • Atherosclerosis
  • Cardiovascular disease prevention.

Research Interests

Professor Kaski's main areas of research include mechanisms and causes of ischaemic heart disease, inflammatory and immunological mechanisms of atherogenesis, rapid coronary artery disease progression, biomarkers of cardiovascular risk, microvascular angina and coronary artery spasms.

Publications

Professor Kaski has authored over 500 scientific papers in peer-reviewed journals, over 200 invited papers, more than 130 book chapters and has edited 9 books on cardiovascular topics, including the European Society of Cardiology Handbook on Cardiovascular Pharmacotherapy.